Fact CheckerSign in

NCT05029193Completed

Effectiveness of Mindfulness After a Stroke

Effectiveness of an Online Mindfulness Program for Stroke Survivors and Their Caregivers

Source: ClinicalTrials.gov · Last updated 10 Jul 2025

Brief summary (registry, in English)

Mindfulness is promising for individuals with neurological disorders and caregivers to improve psychological well-being. This study aims to determine the extent to which a 3-week online mindfulness intervention will improve quality of life and psychological well-being for chronic stroke survivors and their caregivers, compared to a waitlist control.

Status (registry)
Completed
Study type
Interventional
Enrollment
29 (actual)
First submitted
19 Aug 2021
Start date
13 Sept 2021
Primary completion date
30 Nov 2023
Lead sponsor
University of Southern California
Diseases
Stroke
NCT number
NCT05029193

What you commit to

  • Study type: Interventional
  • Participants enrolled: 29
  • From 13 Sept 2021 to the primary completion date, 30 Nov 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Severe language impairments
  • Participation in regular meditation or a mindfulness program in past 3 months

Who the study is looking for

  • Stroke survivor or caregiver of someone who have had a stroke
  • Fluent in English
  • Have access to Internet using a computer, a tablet and/or a smart phone.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Southern California
Coordinator of this site? Confirm its status
Los AngelesUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.